Publication | Open Access

Sublethal Concentrations of Prion Peptide PrP106–126 or the Amyloid Beta Peptide of Alzheimer's Disease Activates Expression of Proapoptotic Markers in Primary Cortical Neurons

Neurodegenerative DiseasesAlzheimer's DiseaseSynaptic TransmissionPrion Peptide Prp106–126Prion DiseaseProtein MisfoldingAmyloid Beta PeptideNeurologyNeuroscienceSublethal ConcentrationsNeuropathologyMedicineSynaptic Signaling